QUARTERLY REPORT

Company

Coeptis Therapeutics Holdings, Inc.

Filed

November 9, 2023

Period of Report

September 30, 2023

Accession Number

0001683168-23-007828

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →